Increase In Initial Order For COVID-19 Supplement.
Pharmaceuticals companies have announced that many of the distributors like Swiss Pharma, Aark Pharma has increased their initial order volume for ArtemiC Rescue, an anti-inflammatory product from COVID-19, by 85%. MGC said it has enough manufacturing capacity to complete the first batch of approximately $ 425,000. “This additional agreement will give more people access to the natural therapeutic benefits of the dietary supplement and alleviate suffering following the successful results of Phase II trials in December,” said CEO Robie Zomer. Many Pharma companies can now have the exclusive right to market Artemis worldwide, with a particular focus on countries that are currently reporting high numbers of coronavirus (COVID-19) cases. The framework agreement provides for a minimum bulk order of 40,000 units per quarter. Meanwhile, ArtemiC has stood the test of time in phase II clinical trials that have been shown to prevent COVID-19 patients from worsening and help them achieve faster c